Toronto - Delayed Quote CAD
Andlauer Healthcare Group Inc. (AND.TO)
53.59
+0.03
+(0.06%)
At close: May 7 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
655,427
650,477
647,952
648,423
440,115
Cost of Revenue
505,533
503,273
500,471
489,576
329,361
Gross Profit
149,894
147,204
147,481
158,847
110,754
Operating Expense
55,608
53,241
51,428
48,502
37,051
Operating Income
94,286
93,963
96,053
110,345
73,703
Net Non Operating Interest Income Expense
-6,182
-5,433
-5,037
-6,259
-6,021
Other Income Expense
5,174
-332
-409
-328
40,758
Pretax Income
93,278
88,198
90,607
103,758
108,440
Tax Provision
23,508
23,730
24,467
27,483
18,486
Net Income Common Stockholders
69,770
64,468
66,140
76,275
89,954
Diluted NI Available to Com Stockholders
69,770
64,468
66,140
76,275
89,954
Basic EPS
1.60
1.60
1.58
1.82
2.30
Diluted EPS
1.58
1.58
1.55
1.79
2.25
Basic Average Shares
40,278
40,278
41,833
41,813
39,036
Diluted Average Shares
40,885
40,885
42,543
42,671
39,036
Total Operating Income as Reported
94,286
93,963
96,053
110,345
73,703
Total Expenses
561,141
556,514
551,899
538,078
366,412
Net Income from Continuing & Discontinued Operation
69,770
64,468
66,140
76,275
89,954
Normalized Income
66,015.14
64,468
66,140
76,275
58,497.47
Interest Income
1,780
2,152
3,170
599
198
Interest Expense
7,962
7,585
8,207
6,858
6,219
Net Interest Income
-6,182
-5,433
-5,037
-6,259
-6,021
EBIT
101,240
95,783
98,814
110,616
114,659
EBITDA
171,771
166,717
166,963
175,068
157,375
Reconciled Cost of Revenue
505,533
503,273
500,471
489,576
329,361
Reconciled Depreciation
70,531
70,934
68,149
64,452
42,716
Net Income from Continuing Operation Net Minority Interest
69,770
64,468
66,140
76,275
89,954
Total Unusual Items Excluding Goodwill
5,020
--
--
0
37,921
Total Unusual Items
5,020
--
--
0
37,921
Normalized EBITDA
166,751
166,717
166,963
175,068
119,454
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,265.14
0
0
0
6,464.47
12/31/2021 - 12/11/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade